Molecular Imaging Services has signed an agreement to establish a commercial radiopharmaceutical production unit at Keele University Science Park in Staffordshire, U.K. The unit will produce PET radiopharmaceuticals. MIS was established in 2002 as a
Molecular Imaging Services has signed an agreement to establish a commercial radiopharmaceutical production unit at Keele University Science Park in Staffordshire, U.K. The unit will produce PET radiopharmaceuticals. MIS was established in 2002 as a joint venture between Phoenix-based Alliance Medical and Dublin-based M2i. Its primary goal is to establish a number of such production units to support the expanded use of PET in the U.K.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.